Similarly, high levels of COL10A1 have been observed in gastric cancer, representing a key independent predictor of poor outcomes [95], probably because of COL10A1-mediated upregulation of lymphoid enhancer-binding factor 1 and Wnt2 [96]. This evidence concerns the gene COL10A1 and gastric cancer.